874. The Cost of Our Drugs: Branded, Generics and Why We Should Care
Session: Named Lecture: John F. Enders Lecture
Thursday, October 4, 2018: 3:30 PM
Room: N Hall D
Rochelle Walensky, MD, MPH, FIDSA, Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA

Rochelle Walensky, MD, MPH, is the Chief of Infectious Diseases and Co-Director of the Medical Practice Evaluation Center at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. Dr. Walensky has been a member of the Cost-effectiveness of Preventing AIDS Complications (CEPAC) team since 1998. Her research interests have focused on HIV/AIDS policy and cost-effective strategies of HIV care in the US and in resource-limited settings. She is internationally recognized for motivating US policy toward the promotion of routine HIV screening and for her work on effective and efficient strategies of HIV care in South Africa. She is a member of the American Society for Clinical Investigation (ASCI), the American Association of Physicians (AAP), and the Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, and she is past Chair of the NIH Office of AIDS Research Advisory Council. She has also been an advisor to the WHO and the UNAIDS. Dr. Walensky received her BA from Washington University in St. Louis (1991), her M.D. from the Johns Hopkins School of Medicine (1995), and her M.P.H. from the Harvard School of Public Health (2001). She trained in Internal Medicine at the Johns Hopkins Hospital (1995-1998) and in Infectious Disease at the MGH/BWH combined fellowship program (1998-2001). She is married to a physician scientist, Loren Walensky, MD, PhD, and is the mother of 3 boys, ages 13, 16, and 18.


Disclosures:

R. Walensky, None

See more of: John F. Enders Lecture
See more of: Named Lecture

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.